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The methodology used to establish tolerable upper intake levels (UL) for nutrients borrows heavily from risk assessment
methods used by toxicologists. Empirical data are used to identify intake levels associated with adverse effects, and
Uncertainty Factors (UF) are applied to establish ULs, which in turn inform public health decisions and standards. Use
of UFs reﬂects lack of knowledge regarding the biological events that underlie response to the intake of a given nutrient,
and also regarding the sources of variability in that response. In this paper, the Key Events Dose-Response Framework
(KEDRF) is used to systematically consider the major biological steps that lead from the intake of the preformed vitamin A
to excess systemic levels, and subsequently to increased risk of adverse effects. Each step is examined with regard to factors
that inﬂuence whether there is progression toward the adverse effect of concern. The role of homeostatic mechanisms is
discussed, along with the types of research needed to improve understanding of dose-response for vitamin A. This initial
analysis illustrates the potential of the KEDRF as a useful analytical tool for integrating current knowledge regarding
dose-response, generating questions that will focus future research efforts, and clarifying how improved knowledge and data
could be used to reduce reliance on UFs.
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INTRODUCTION
Nutrients are bioactive substances classiﬁed as either
macronutrients (energy-producing substances—carbohydrates,
fats, and proteins), or micronutrients (vitamins, minerals, and
electrolytes). While the various nutrients are required for nor-
mal growth, maintenance, and repair of tissue, excess nutrient
intake can cause adverse effects. Thus, considerable effort has
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gone toward identifying “safe” nutrient intake levels. For mi-
cronutrients, the methods for setting “tolerable upper intake
levels” or “safe upper levels” have borrowed from risk assess-
ment methodologies used by toxicologists for environmental
chemicals, in which data from experimental, observational, and
clinical studies are used to identify both the nature of effects
resulting from excess intake and the intake levels associated
with such effects (Food and Nutrition Board, 1998; Institute
of Medicine 2006; World Health Organization/Food and Agri-
culture Organization of the United Nations, 2006; Taylor and
Yetley, 2008; FSA, 2003; SCF, 2006).
As is the case with many environmental chemicals, the low-
est nutrient intake level associated with an adverse effect is
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generally considered to represent a “threshold” level, such that
any intake at or above that threshold level is expected to pose a
health risk (with the speciﬁc nature of the risk being dependent
on the type of nutrient and the actual intake level). To account
for differences, for example, between experimental species and
humans or among individual humans, Uncertainty Factors (UF)
are applied to the empirically-observed threshold levels to gen-
erate reference values of use for various public health purposes.
Efforts to establish such values are not as robust or reﬁned as
would be desired, due to signiﬁcant data deﬁciencies for many
substancesandalsoduetovariousmethodologicalissues,partic-
ularly relating to the ability to select appropriate UFs (Renwick
and Walker, 2008; Renwick 2006).
Nutrientsdifferfromenvironmentalchemicalsinthatadverse
effects may result from either inadequate intake (of an essential
nutrient), or excess intake (of most nutrients). Thus, for many
nutrients,twothresholdlevelsarepresumedtoexist:1)anintake
level that must occur on a regular basis to prevent the adverse
effectsofdeﬁciency,and2)anintakelevelthatmustbeexceeded
on a regular basis for a toxic effect to occur. Between these two
thresholds, there is a range of safe and sufﬁcient nutrient intake
levels.
Nutritionalscientistshaveevaluated,onanutrientbynutrient
basis, available data and have identiﬁed values associated with
such upper and lower thresholds. For example, in North Amer-
ica, the Institute of Medicine (IOM) is charged with identifying
DietaryReferenceIntakevalues(DRIs),whichareusedforava-
riety of purposes (e.g., food and nutrition programs and public
policies, research design and evaluation, population monitor-
ing, patient counseling, etc.). DRIs are a set of nutrient-based
reference values for intakes, established for speciﬁed life-stage
groups. They include the Estimated Average Requirement, de-
ﬁned as the value at which 50% of the population will have
sufﬁcient intake; the Recommended Dietary Allowance (RDA),
deﬁned as a level that will cover the needs of essentially all
individuals; and the Tolerable Upper Intake Level (UL), the
highest level of daily nutrient intake that is likely to pose no risk
of adverse health effects for almost all individuals (Institute of
Medicine, 2006).
Nutrient intake levels typically vary over time and, on any
given day, may fall short of RDAs or go above ULs. But var-
ious physiological homeostatic mechanisms exist to maintain
systemic and cellular nutrient levels within a safe and adequate
range.1 Thesemechanismsprovidestabilitytotheorganism,and
allow the body to adjust to the intake of a wide variety of foods,
differing in nutrient contents, as present in most human diets.
Homeostatic mechanisms also allow for adjustments to normal
physiological states, such as pregnancy. However, homeostatic
mechanisms may be inadequate or overwhelmed. These mech-
anisms cannot compensate when long-term nutrient intake is
very low. Conversely, when long-term nutrient intake is very
1Throughout this discussion, the phrase “nutrient levels” is intended to refer not only
to the parent nutrient compound, but also to metabolites or other downstream effectors
generated by the nutrient.
high,homeostaticmechanismsmaybecome“saturated,”orthey
may become undermined by altered pathophysiological states
(e.g., certain disease states, drug actions etc.). When homeo-
static mechanisms fail, adverse effects (nutrient deﬁciency or
toxicity) may ultimately result.
Asexplainedintheintroductorypaperofthisseries(Julienet
al., 2009), a systematic analysis of individual Key Events along
the mode-of-action pathway between intake and effect of con-
cern may contribute new insight with regard to dose-response,
biological thresholds, and safe intake levels. The “Key Events
Dose-Response Framework” (KEDRF) provides an organizing
structure for such an analysis whereby each Key Event is con-
sidered with regard to its fundamental biology (including the
dose-response relationship for the individual event), and with
regard to its inﬂuence on the overall dose-response relationship
for the effect of concern. Figure 1, reproduced from the ﬁrst
paper in this series, illustrates this conceptual framework.
As shown in Fig. 1, various mechanisms (e.g., homeostatic
mechanisms, repair, adaptive, immune) may engage at individ-
ual events to maintain a normal physiological environment, and
therebyinﬂuencetheoutcomeoftheevent.Thus,thecapacityof
such mechanisms to maintain the environment within a normal
homeostatic range (HR) will likely inﬂuence the overall dose-
response relationship. Events with such mechanisms may be
considered to be “control points” in the overall pathway. While
every event in the pathway must occur in order to achieve the
effect of concern, it is conceivable that a particular event could
disproportionately inﬂuence its likelihood. Such an event could
be hypothesized to be a “determining event” in that the outcome
of this event tends to determine whether the effect of concern
occurs, or not.
It is important to note that the biological interactions that
occur at individual key events may be affected by a variety of
factors (e.g., genetics, life stage, health status, behavioral pat-
terns); these factors may exert their inﬂuence by modifying the
effectiveness of homeostatic mechanisms. Understanding the
conditions under which homeostatic control can be undermined
or lost is fundamental to better characterizing the dose-response
fornutrients,andfundamentaltocharacterizingthresholdvalues
as well as the variability in their values.
APPLYING THE GENERIC KEY EVENTS
DOSE-RESPONSE FRAMEWORK TO VITAMIN A
Overview
Knowledge of speciﬁc key events along the pathway from
intake to effect of interest is incomplete for most nutrients, and
even less is known about homeostatic mechanisms operating
at key events. For vitamin A, however, a fair amount is known.
Thus,thisvitaminwasselectedforaninitialcasestudytoexam-
ine the potential value of the KEDRF for nutrients. The present
study will be limited to considering adverse effects from ex-
cess intake of preformed vitamin A (retinol). Future work may710 A. C. ROSS ET AL.
Figure 1 SchematicoftheKeyEventsDose-ResponseFramework.TheKeyEventsDose-ResponseFrameworkorganizesinformationonthemultiplebiological
events that occur between an initial dose and the speciﬁed effect of concern. Events are indicated generically; but a given pathway may have several kinetic and
dynamic events, and may include events that are reversible. In theory, each event may be characterized by its dose and its outcome. Various mechanisms may be
available at some events to respond to conditions caused by the agent.
expand consideration to effects resulting from inadequate in-
take, and may delve deeper into issues and questions raised in
this ﬁrst case study. The remainder of this paper will:
• Brieﬂy review the types of adverse effects associated with
retinol.
• Describe the pathway of Key Events that leads, potentially,
fromtheintakeofpreformedvitaminAtotheeffectofconcern
(speciﬁed for this study as inappropriate gene expression).
• Discuss what is known about dose-response and homeostatic
mechanismsateachKeyEvent,includingimplicationsforthe
existence of thresholds at the event, and implications regard-
ing the role of the event in protecting against the effect of
concern.
• Assess lessons learned regarding retinol and future research
needs.
• Assess the value of the Key Events Dose-Response Frame-
work as applied to retinol.
Adverse Effects Associated with Inadequate or Excess
Intakes of Vitamin A
Vitamin A is a family of molecules that includes retinol and
potent bioactive retinol metabolites that are required for health.
Asreviewedelsewhere(InstituteofMedicine,2001),inadequate
vitamin A status can potentially lead to visual abnormalities,
impairedfertility,adecreasedimmuneresponse,decreasedbone
growth, and impaired maintenance of the surface lining of the
eyes and epithelial lining of the respiratory, urinary, and intesti-
nal tracts. Vitamin A also plays a role in gene regulation and
inguidingembryonicdevelopment(Clagett-DameandDeLuca,
2002). In pregnant women, both inadequate intake and excess
intake may lead to teratogenic effects (McCaffery et al., 2003).
Excess intake of vitamin A or its products has been associ-
ated with organ damage and weakened tissues (e.g., bones) in
addition to teratogenic effects.
It is important to note that adverse effects resulting from an
excess or deﬁciency of vitamin A are almost certainly a product
of both dose level and dose frequency. Acute vitamin A toxicity,
resulting even in death, can occur after a single dose or several
extremely high doses of vitamin A; acute toxicity can also oc-
cur with moderately high intakes of vitamin A during critical
physiological periods, such as early pregnancy. Data from ob-
servational studies suggest that unhealthful outcomes can also
result from more modest elevations in vitamin A intake (via diet
or supplements) over a prolonged time period. Similarly, ad-
verse effects from insufﬁcient intake occur only after prolonged
or chronic deﬁciency. Examples of the integrated effects of dose
level and frequency are shown in Table 1.
Toxicity from excess dietary vitamin A intake results from
highsystemiclevelsoffreeretinol(i.e.,retinolthatisnotstored,
esteriﬁed, or bound to chaperone proteins) and subsequently,
increased levels of the metabolite of retinol, retinoic acid (RA).
As illustrated in Fig. 2, there are two main etiologies underlying
the effects from excess intake:A CASE STUDY WITH (VITAMIN A) RETINOL 711
Table 1 Examples of adverse effects associated with dietary intake of vitamin A. Effects are a product of dose level and dose frequency
Vitamin A Intake: Level and Frequency Potential Clinical Effects (Institute of Medicine, 2001)
Extremely high acute intake (Excessive consumption of supplements, or
foods extremely high in vitamin A)
Severe toxicity or lethality, likely due to rapid changes in membranes (ﬂuid and
hemodynamics) and possibly inappropriate gene expression.
Very high acute intake Teratogenicity, likely resulting from inappropriate gene expression.
Moderately high chronic intake Organ damage affecting metabolism (e.g., liver damage), likely as a result of
membrane damage and/or inappropriate gene expression and their sequelae –
e.g., ﬁbrosis, or altered immune/inﬂammatory functions.
Marginally high chronic intake Weakened tissues (possible bone fragility).
Chronic insufﬁcient intake Impaired night vision, blindness, reduced reproductive performance, poor
antibody response, decreased bone growth, and impaired maintenance of the
surface lining (e.g., skin, intestinal tract).
• Both RA (and possibly its metabolites) as well as free retinol
itself(eithersystemicorcellular)aresolubleincellularlipids,
and may intercalate into membranes, destroying membrane
integrity and causing cell lysis. Thus, multiple mechanisms
are in place to keep retinol in a bound or esteriﬁed form.
• Excess levels of RA may also lead to increased binding to
retinoid receptor proteins and subsequently, increased stim-
ulation of retinoid-responsive genes. Inappropriate gene ex-
pressioncanresultinaberrantcelldifferentiationorinduction
of apoptosis (Soprano and Soprano, 1995; Williams and Iat-
ropoulos, 2002; Yin et al., 2005).
Figure 2 General etiologies leading to adverse effects from excess dietary
vitamin A.
Overview of Key Events for Retinol
The absorption, fate, and target tissue activity of ingested vi-
taminAanditsmetaboliteshavebeenreviewedelsewhere(Ross
and Harrison, 2007; Harrison, 2005) and will be described only
brieﬂy here. Figure 3 summarizes Key Events along the path-
wayfromvitaminAintaketotheeffectofconcern,whichinthis
case is inappropriate gene expression. Each of these Key Events
willbesystematicallyexaminedwithregardtoitsdose-response
characteristics, homeostatic mechanisms, and implications for
thresholds.
In humans, dietary Vitamin A is ingested in two primary
forms: i) preformed vitamin A (retinyl esters (RE) in organ
meats,ﬁsh,wholemilk,eggs)andii)carotenoids,someofwhich
are vitamin A precursors (in vegetable and fruit products), the
most prominent being β-carotene. In addition, dietary supple-
ments and fortiﬁed foods may contain preformed vitamin A,
carotenoids, or a mixture of these (Institute of Medicine, 2001;
Ross and Harrison, 2007).
Some carotenoids are converted to retinol in the lumen, via
a process that is not very efﬁcient. For example, it is generally
assumed that 12 molecules of β-carotene of fruit or vegetable
origin will on average convert to 1 molecule of retinol in the
human(InstituteofMedicine,2001).However,theconversionof
β-carotene to retinol from certain plant sources such as spinach,
may be less efﬁcient (∼20:1) (Institute of Medicine, 2001).
Only about 15–30% of an oral dose of pure ß-carotene in oil (its
most bioavailable form) will be absorbed (Harrison, 2005). The
efﬁciency of carotenoid absorption may be increased somewhat
when systemic vitamin A is low, and reduced somewhat when
it is high. In general, however, carotenoids are metabolized and
absorbed at a low rate, and do not perturb systemic vitamin
A homeostasis. Thus, ingestion of preformed vitamin A is the
predominant source of systemic retinol, and the present study
will focus on retinol obtained via this form.
Analysis of Individual Key Events for Preformed Vitamin A
Uptake from Lumen into Enterocytes
Preformed dietary vitamin A is rapidly and efﬁciently hy-
drolyzed to retinol in the intestinal lumen. About 70% of pre-
formed vitamin A is absorbed as retinol into enterocytes, appar-
ently via carrier-mediated passive absorption.
The rates of hydrolysis and absorption are quite constant
regardless of the ingested dose, that is, the dose-effect curve
for these events is linear, i.e., there is no evidence that either
hydrolysis or absorption is “thresholded.”2 There is also no
evidence that either RE hydrolysis in the lumen or absorption
2The term “thresholded” is commonly used in the ﬁeld of chemical risk assessment.
It refers to a dose-response relationship that is characterized by a biological threshold and
a non-linear or discontinuous dose-response curve. A biological threshold is a transition
point between the highest dose that will not elicit a speciﬁed biological effect, and the
lowest dose that will (see Appendix to Julien et al. 2009 for further discussion).712 A. C. ROSS ET AL.
Figure 3 Overview of Key Events between dietary intake of preformed vitamin A and target tissue activity that affects transcription.
into enterocytes is signiﬁcantly regulated in a manner related
to an individual’s systemic vitamin A status. Thus, there is no
evidence that this ﬁrst key event is an important control point
for regulating systemic dose or target tissue levels in response
to an excess intake of vitamin A.
Initial (Intestinal) Metabolism and Distribution
Once retinol is absorbed into enterocytes, most of it is re-
esteriﬁedtoformREandpackagedintochylomicrons,whichare
then extruded into the lymph system and then into blood, where
theyareconvertedintosmallerchylomicronremnants(Rossand
Harrison, 2007; Harrison, 2005). A small amount of absorbed
retinol in the enterocyte may not be esteriﬁed and packaged
into chylomicrons, and instead may be passed directly into the
blood as oxidized retinoic acid. Thus, the intestine, especially
after ß-carotene or vitamin A-containing meals, may contribute
to the production of relatively small amounts of acidic retinoids
thatarepresentinplasma,andplasmalevelsmayincreaseinthe
post-absorptive period (Wang et al., 1992; Wang et al., 1993;
H´ ebuterne et al., 1995).
There is no evidence that this key event—esteriﬁcation of
retinol and packaging into chylomicrons—is regulated based
on systemic vitamin A status. In fact, the functional capacity
for absorption remains strong across a wide range of vitamin A
status, even in cases of vitamin A overload or vitamin A deﬁ-
ciency (Randolph and Ross, 1991; Ross and Harrison, 2007).
There may be some homeostatic feedback regulation via circu-
lating RA levels of the enzyme that cleaves some carotenoids
(especially ß-carotene) to form retinaldehyde, and then retinol
(Bachmann et al., 2002); however, since even in its most
bioavailable form, only ∼ 30% of ß-carotene will be absorbed,
this feedback mechanism is unlikely to be an important control
point for regulating the availability of retinol for packaging and
distribution.
Uptake and Storage in the Liver
The liver is the main storage organ for retinol and plays a
central role in retinol metabolism. Most (60–80%) of the chy-
lomicron remnants holding RE are taken up by liver receptors
and incorporated into hepatocytes, while a lesser portion (20–
40%)istakenupintoextrahepatictissues.Chylomicronremnant
uptake into liver is both rapid and efﬁcient, and esteriﬁed retinol
is passively assimilated into hepatocytes as a component of the
chylomicron remnant (Ross and Harrison, 2007). Thus, uptake
into the liver is not homeostatically regulated. After uptake, es-
teriﬁed retinol in chylomicrons is rapidly hydrolyzed in liver
parenchymal cells (hepatocytes). Within a few hours, newly
formed RE is found in liver storage cells (stellate cells).A CASE STUDY WITH (VITAMIN A) RETINOL 713
Two enzymes are known to catalyze esteriﬁcation of retinol
[reviewed in Ross and Harrison, 2007; Harrison, 2005].
Lecithin—retinol acyltransferase (LRAT) esteriﬁes retinol in
numerous tissues. In the small intestine, LRAT esteriﬁes retinol
that is bound to cellular retinol binding protein II (CRBP-II). In
the liver (mostly in stellate cells), LRAT esteriﬁes retinol bound
to cellular retinol binding protein I (CRBP-I). LRAT is also
active in the retina, testis, and other tissues. A second enzyme
in liver, acyl-CoA—retinol acyltransferase (ARAT) is capable
of esterifying retinol that is not associated with a CRBP (Yost
et al., 1988). This activity may be important at higher concen-
trations of retinol, if CRBPs become saturated. The molecular
identity of ARAT is currently unknown; it may be a form of
diacylglycerol acyltransferase (DGAT) and its activity may rep-
resent side reactions of enzymes involved in the pathway of
triglyceride biosynthesis (Orland et al., 2005; Yen et al., 2005).
ARAT activity is not as well characterized as LRAT and there
is no evidence at present that ARAT is speciﬁc for vitamin A,
or saturated by high vitamin A. Thus, LRAT is the principal en-
zyme involved in retinol esteriﬁcation in both the liver and the
enterocyte (Ross and Zolfaghari, 2004; O’Bryne et al., 2005).
LRATexpressionandactivitygenerallycorrelateswithcircu-
lating retinol levels. LRAT activity falls to almost undetectable
levels in states of low vitamin A status (Randolph and Ross,
1991). This decrease in esteriﬁcation and storage of retinol
likely serves to preserve retinol for oxidation and/or secretion
to plasma. On the other hand, liver LRAT activity remains ad-
equate, and may increase slightly, to deal with increased intake
of vitamin A (especially preformed vitamin A)3 (Ross and Har-
rison, 2007; Randolph and Ross, 1991).
After long-term vitamin A supplementation, however, LRAT
expressioninliverrisesonlyslightlyabovecontrollevels(Daw-
son et al., 2000) This suggests that LRAT is not highly “elastic”
intheupwardsdirection,i.e.,thereisnoextensivecompensatory
upregulation of LRAT, at least in the liver (Ross and Zolfaghari,
2004), although RE storage increases. Thus, at some level of
intake liver LRAT may become saturated acutely with extreme
vitamin A intake, or slowly after long-term intakes of high vi-
tamin A. In such situations, the dose-effect relationship for this
key event may reach a threshold, i.e., an increase in retinol in-
take does not lead to an adequate increase in LRAT activity and
storage.Instead,itleadstoincreasedcirculatinglevelsofretinol
and retinyl esters, and increased likelihood of disruptions in cell
functions due to unesteriﬁed retinol or its metabolite within
cells.
The liver’s capacity to store vitamin A is considered high
when compared to usual daily intakes (Randolph and Ross,
1991), and the liver apparently accommodates moderately ele-
vated intakes over time without adverse effects (Dawson et al.,
2000). The amount of stored vitamin A in the liver increases
as intake exceeds the amount required for use and the rate of
3LRAT also increases in some extrahepatic tissues, such as the lungs, when vitamin
A or retinoic acid are above usual levels (Ross et al., 2006). In addition, ARAT activity
becomes active in liver and intestine when retinol is present in high concentrations.
clearance (Green and Green, 1994). The storage capacity of
the liver is not inexhaustible, however. Research suggests that
when liver vitamin A stores reach a very high level (>300 µg/g
liver), plasma RE begins to accumulate (Olson, 1984); this indi-
cates the liver’s lack of capacity to process and store additional
vitamin A.
Thus, this key event—esteriﬁcation of retinol by LRAT to
enable storage in the liver—appears to be an important control
pointinregulatingsystemicvitaminAlevels.Thereisevidence,
however, that this control mechanism can be overwhelmed by
very high acute intake of preformed vitamin A, or by high long-
term intake.
Release of Stored Retinol into Plasma
Signals for the liver to release stored vitamin A into cir-
culation are not precisely known, but once retinol is freed
from its storage form, it is bound to retinol binding protein
(RBP) within the hepatocyte and then secreted into circulation
as a dimolecular complex (retinol-RBP, also known as holo-
RBP) (Soprano and Blaner, 1994). Retinol-RBP then joins with
another protein (transthyretin) in the circulation, forming a
retinol-RBP-transthyretin (retinol-RBP-TTR) complex. This
trimolecular complex prevents retinol from being nonspeciﬁ-
cally delivered to tissues in its unbound (toxic) form and also
prevents ﬁltration of retinol bound to RBP by the kidney and
loss in the urine. Except in cases of hypervitaminosis A,4 the
major form of circulating vitamin A is the retinol-RBP-TTR
complex. Other minor circulating forms include RE in lipopro-
teins, a minor amount of free retinol, small amounts of retinoic
acid (RA), and glucuronide conjugates of both retinol and RA.
Oxidative metabolites of retinol and retinoic acids have also
been detected in blood and bile (e.g., 4-oxo-retinol and 13-cis-
4-oxo-RA) and rise after vitamin A supplementation (Eckhoff
et al., 1991; Hartmann et al., 2001; Arnhold et al., 2002).
Retinol bound to RBP recirculates between liver and extra-
hepatic tissues multiple times before being degraded (Green
and Green, 1994). Except in cases of vitamin A deﬁciency or
excess, the concentration of retinol in plasma, as a retinol-RBP-
TTR complex, is kept essentially constant in any given indi-
vidual via mechanisms that are centered in the liver. Kinetic
modeling studies have indicated that the retinol disposal rate
(irreversible loss) is only modestly increased when vitamin A
intakeiselevatedchronicallyoracutely(GreenandGreen,1994;
Cifelli et al., 2008). The liver, however, appears to detect cir-
culating plasma retinol levels, as liver LRAT activity (Dawson,
2000) and retinol turnover are correlated with plasma retinol
concentrations (Kelley and Green, 1998). There may be a feed-
back loop whereby low circulating levels of RA, a principal
metabolite of vitamin A, or other metabolites signal the liver to
4With hypervitaminosis A (acute or chronic), RE may exceed retinol-RBP-TTR as the
major form of circulating VA. RE may be released directly from the liver and chylomicron
containingREmaynotbetakenupbyliver.SomespeciesareknowntosecreteREfromthe
liverinlipoproteins(Wilsonetal.,1987)andthiscouldbe,inpart,thecaseinhumans.Also,
some chylomicron may exchange RE with circulating lipoproteins before being cleared.714 A. C. ROSS ET AL.
release vitamin A from its storage form, RE, and convert these
stores (via retinyl hydrolase) back into retinol. Over time, liver
storage levels may decrease slowly, or increase very slowly
to very rapidly, in response to intake levels and correspond-
ing LRAT activity. Across a population, normal liver storage, as
inferredfromhomeostaticallycontrolledplasmaretinolconcen-
trations, ranges from ∼20–300 µg retinol/gram of liver (Olson,
1984).
In summary, mechanisms that control retinol storage in the
liver appear to be critical “control points” in the mode-of-action
pathway whereby excess vitamin A intake can lead to toxicity.
These mechanisms serve to regulate circulating vitamin A lev-
els. As circulating vitamin A levels fall, the release of retinol
from liver storage increases to compensate; as circulating vita-
minAlevelsrise,theLRATstorageactivityintheliverincreases
and release of retinol from liver storage decreases.
The capacity of these regulatory mechanisms can be over-
come, however, by saturation of the storage enzyme LRAT.
Long-term exposure to excess vitamin A can also lead to liver
ﬁbrosis and compromised ability to store vitamin A (Nollevaux
et al., 2006). Either of these conditions is expected to greatly
increase the probability of an adverse effect. Saturated LRAT
activity could be an early indicator of potential toxicity except
that LRAT activity cannot be readily measured in vivo. Thus,
circulating biomarkers capable of reﬂecting liver LRAT activity
would be very valuable.
Circulating plasma retinol-RBP-TTR levels are relatively
easy to measure but these are not a good indicator of vitamin
A status as levels are kept essentially constant (at the expense
of ﬂuctuating liver stores).5 An acute intake of vitamin A will
not lead to an increase in plasma levels of retinol bound to RBP
except in vitamin A deﬁciency. When there is deﬁciency, newly
absorbed vitamin A will not be stored; rather, it will be bound
in the liver to RBP and go directly into circulation. This is made
possible by a build up of RBP stores in liver in response to deﬁ-
ciency. This build up ensures that RBP will be readily available
to carry retinol to tissues as soon as there is intake. While liver
RBP levels increase when there is vitamin A deﬁciency (So-
prano and Blaner, 1994), liver and plasma RBP levels (which
correspond to circulating retinol) do not increase in states of
vitamin A excess.
CirculatingRElevelsarealsorelativelyeasytomeasure,and
doﬂuctuatewithvitaminAintake(i.e.,maybehigherpostpran-
diallyifthemealisrichinvitaminA).Several studieshaveused
circulating RE, retinol, or RA metabolites to assess increased
potential for adverse effects from intake of vitamin A supple-
ments or foods with high vitamin A content (van Vliet et al.,
2001; Hartman, 2001). Measures of circulating RE as a percent
of total serum vitamin A may also be useful as an indicator
of vitamin A status. Circulating RE is normally present in the
5While plasma retinol levels are not a sensitive indicator of status, they have some
predictive value, as epidemiological data have correlated very low levels of plasma retinol
levels to certain types of disease risk (e.g., impaired growth, eye disease, mortality from
infectious disease) (Underwood, 1994).
range of 2–11% of the total serum vitamin A (Krasinski et al.,
1989; Smith and Goodman 1976). If RE in plasma (as percent-
age of total circulating vitamin A) in a fasting state exceeds this
range, this is an indicator of excessive vitamin A status (intake
exceeds clearance, and storage capacity of liver has been ex-
ceeded). Thus, an increase in proportion of circulating RE may
beanindicator ofvitaminAoverload, butnotanearlyindicator,
as increased (fasting) RE levels indicate likely liver damage.
Uptake and Storage in Extrahepatic Tissue
The mechanism for the uptake of retinol into extrahepatic
tissues is unknown, but may involve uptake by a speciﬁc mem-
brane receptor (Kawaguchi et al., 2007). Alternatively, retinol
may dissociate from the retinol-RBP-TTR complex and diffuse
into cells where it is then be converted into its storage form, RE,
by LRAT. Another source for extrahepatic uptake is circulating
chylomicron remnants containing RE; these are also taken up
via an unknown mechanism.
Due to lack of knowledge regarding uptake mechanisms, the
role of extrahepatic uptake in controlling the consequences of
excess vitamin A intake cannot be well characterized. There is
no evidence, however, to suggest that uptake mechanisms may
control the amount of circulating retinol taken into extrahepatic
tissues. But, LRAT activity in extrahepatic tissues, such as lung,
may be increased with an increase in circulating vitamin A
(Ross et al., 2006). It is not known whether LRAT capacity
in extrahepatic tissue becomes saturated in cases of vitamin A
overload, or whether there is a limit to upregulation of LRAT
expression.
Production and Metabolism of Bioactive Metabolites
(Especially RA)
Bioactive retinoids (e.g., RA) in extrahepatic tissue are de-
rivedfromstoredRE,fromrecentlydeliveredchylomicronrem-
nants, and from retinol taken up from circulating retinol-RBP-
TTR. RA plays a critical role in regulating gene expression, es-
pecially during development (Underhill et al., 1995; Zile 1998).
However, an excess of retinoids can potentially lead to an in-
appropriate expression of retinoid responsive genes and also
damage the cell surface and intracellular membranes. High in-
takes of RA in experimental animals have been shown to cause
teratogenicity,liverabnormalities,alteredmetabolism,andbone
fragility. Less is known about whether metabolites formed from
RA are directly toxic, and if so, at what concentrations. RA
metabolites probably do not alter gene expression very signiﬁ-
cantly,ascomparedtotheverypotentactivityofRA(Perlmann,
2002).
As retinoids are potent bioactive substances, systems have
evolved for the control of retinoid levels. Enzymes responsible
for RA production (biogenesis from retinol) and RA oxida-
tion have been implicated in controlling intracellular RA levels.
There is considerable evidence that at elevated concentrations,
RA induces its own metabolism (Perlmann, 2002; Wang et al.,A CASE STUDY WITH (VITAMIN A) RETINOL 715
2002). Several CYP genes and proteins, present in the liver
and extrahepatic tissues, have been implicated in RA oxidation
(formation of hydroxyl and keto metabolites, which are fur-
ther conjugated and then excreted). Of these, the CYP26 family
has been most extensively studied and the mode of regulation
of CYP26A1 by RA has been deﬁned at the molecular level
(Wang et al., 2002). Metabolic studies in vivo (humans and ex-
perimental animals) provide evidence that metabolites similar
tothoseformedinvitrobyCYP26A1arepresentinplasmaafter
acutevitaminAsupplementation(PennistonandTanumihardjo,
2005) or consumption of high vitamin A foods (Arnhold et al.,
1996), and after therapeutic treatment with RA or other related
retinoids (van Vliet et al., 2001). Retinoid biokinetic studies in
animals and clinical studies in humans have indicated that RA
metabolism is induced by RA; however, the dose-response rela-
tionship between RA concentration, oxidative activity (CYP26
or other enzymes), and metabolite formation is not well
known.
In summary, these data form a strong basis for the hypothe-
sis that RA levels are closely monitored and regulated in vivo,
perhaps through several different mechanisms. These mecha-
nisms may include “thresholds” for inducing metabolism. RA
metabolite levels may be useful as indicators of excessive RA,
as they may mirror the need to catabolize RA.
Retinoid Activity in Cell Nuclei
In the cell nucleus, cellular RA binding proteins (CRABP-
I and CRABP-II) bind speciﬁc isomers of RA (e.g., all-trans
RA) and regulate the activity of retinoid responsive genes.6 The
mechanismofactionismediatedbytwomajorreceptorfamilies,
the RAR and the RXR receptors, which exist in alpha, beta, and
gamma forms. These receptors subsequently bind to speciﬁc
DNA response elements, RARE or RXRE, thereby affecting
gene transcription. Although RXRs may bind to one another to
form homodimers, they most frequently bind to RARs to form
heterodimeric complexes. RXRs also bind as heterodimers to
several other types of nuclear transcription factors, and thus
mediate cross-talk among different signaling pathways that af-
fect the expression of many genes (Rochette-Egly, 2005).
The existence of homeostatic mechanisms within the cell
nucleus to control effects from excess vitamin A intake, or RA
production, is not clear. Vitamin A deﬁciency lowers the ex-
pression of RAR-ß, which conversely is induced in most cells
by RA (DeLuca, 1991), but it is not known whether vitamin
A overload affects the expression of any RARs or RXRs. Vi-
tamin A status has no effect on the expression of CRABP-I,
although CRABP-II expression can be induced in some tis-
sues by all-trans retinoic acid (Astrom, 1994). Thus, CRABP-II
may play a role in controlling free RA by sequestering excess
amounts.
6Other speciﬁc vitamin A binding proteins are present in the retina’s photoreceptor
cells and in retinal pigment epithelial cells.
DISCUSSION
This initial Key Events Dose-Response Analysis for vitamin
A has provided insight at two levels. It has shed light on spe-
ciﬁc biological events that determine whether high intake of
vitamin A will lead to adverse effects. It has also revealed the
potential of the KEDRF as a new analytical tool for examining
dose-response relationships and for using dose-response data to
inform public health decision making.
With regard to vitamin A, this analysis supports the hypothe-
sisthatsaturationofliverLRATactivityisa“determiningevent”
intheKeyEventspathway;suchsaturationgreatlyincreasesthe
likelihood that high intake levels will lead to excess circulating
retinolandRE,andconsequentlyagreatlyincreasedprobability
of toxicity. The analysis also revealed critical research needs,
including: i) characterizing the dose-response relationship for
liver LRAT saturation, ii) identifying, and quantitatively char-
acterizing, sources of variability at important key events (e.g.,
at control points), and iii) characterizing the role of downstream
events (e.g., regulation of RA metabolism, extrahepatic storage,
or sequestration of retinoids) in protecting target tissues when
liver LRAT storage activity is compromised. Because these re-
search needs were generated in the context of a KEDRF, any
resulting data will feed directly into a reﬁned understanding of
thedose-responserelationshipforvitaminA.Thepresentanaly-
sisalsosuggestedcandidatebiomarkersthatshouldbeevaluated
further aspotential indicators ofvitamin Aoverload. Additional
research is needed to further examine biomarkers for a range of
purposes, for example, to assess overall vitamin A status, and to
quantify interindividual variability in capacity of homeostatic
mechanisms.
More fundamentally, this vitamin A case study illustrates the
value of the KEDRF as an analytical approach for integrating
and utilizing available knowledge, and for generating questions
that will focus future research efforts. The KEDRF facilitates
identiﬁcationofthemostcriticalevents,i.e.,determiningevents
within the overall mode-of-action, and also helps tease out the
role of speciﬁc homeostatic mechanisms in countering the ef-
fects of excess intake. A more robust understanding of these
events and mechanisms provides the necessary foundation for
characterizing and quantifying sources of variability (genetic,
behavioral, life stage, etc.) in response to a given dose. In turn,
this provides the evidence necessary to reduce reliance on Un-
certainty Factors and other assumptions when identifying safe
and adequate intake levels for a population or sub-population.
Thus the KEDRF approach emerges as a useful new way of
thinking about dose-response and the process for setting recom-
mendations for nutrient intakes.
This analytical approach should be further tested by appli-
cation to other endpoints (including effects from vitamin de-
ﬁciency) and other vitamins and minerals. The present case
example used a vitamin for which there is a relatively good
understanding of mode-of-action and Key Events. It might be
instructive to test the broader value of this analytical approach
on a vitamin or mineral for which much less is known.716 A. C. ROSS ET AL.
In addition to broadening application to other nutrients and
endpoints, it would be valuable to “deepen” this KEDRF analy-
sis for vitamin A. This would involve compiling and evaluating
current knowledge regarding Key Events for vitamin A as seen
from a range of perspectives (molecular, cellular, systemic, or-
ganismal, and population). This strategy would leverage data
and knowledge from multiple disciplines toward a single goal
of reﬁning the characterization of threshold doses (both for safe
intake, and for adequate intake) for vitamin A.
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